DOCSLIB.ORG

Network Organization of the Huntingtin Proteomic Interactome in Mammalian Brain

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Network Organization of the Huntingtin Proteomic Interactome in Mammalian Brain Neuron NeuroResource Network Organization of the Huntingtin Proteomic Interactome in Mammalian Brain Dyna I. Shirasaki,1,8,10 Erin R. Greiner,1,8,10 Ismael Al-Ramahi,9 Michelle Gray,1,6,7,11 Pinmanee Boontheung,8 Daniel H. Geschwind,1,2,3,6,7 Juan Botas,9 Giovanni Coppola,1,3,6,7 Steve Horvath,2,4 Joseph A. Loo,5,6,8,* and X. William Yang1,6,7,* 1Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences 2Department of Human Genetics 3Department of Neurology, Program in Neurogenetics 4Department of Biostatistics 5Department of Biological Chemistry 6David Geffen School of Medicine at UCLA 7Brain Research Institute 8Department of Chemistry and Biochemistry University of California, Los Angeles, CA 90095, USA 9Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA 10These authors contributed equally to the work 11Present address: Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham AL 35294, USA *Correspondence: [email protected] (J.A.L.), [email protected] (X.W.Y.) http://dx.doi.org/10.1016/j.neuron.2012.05.024 SUMMARY of the striatal medium spiny neurons (MSNs) and, to a lesser extent, the deep layer cortical pyramidal neurons (Vonsattel We used affinity-purification mass spectrometry to and DiFiglia, 1998). The disease is caused by a CAG repeat identify 747 candidate proteins that are complexed expansion resulting in an elongated polyglutamine (polyQ) with Huntingtin (Htt) in distinct brain regions and stretch near the N terminus of Huntingtin (Htt) (The Huntington’s ages in Huntington’s disease (HD) and wild-type Disease Collaborative Research Group, 1993). HD is one of nine mouse brains. To gain a systems-level view of the polyQ disorders with shared molecular genetic features, such as Htt interactome, we applied Weighted Correlation an inverse relationship between the expanded repeat length and the age of disease onset, and evidence for toxic gain-of-function Network Analysis to the entire proteomic data set as a result of the polyQ expansion (Orr and Zoghbi, 2007). to unveil a verifiable rank of Htt-correlated proteins However, each of the polyQ disorders appears to target a distinct and a network of Htt-interacting protein modules, subset of neurons in the brain leading to disease-specific symp- with each module highlighting distinct aspects of toms. Hence, it is postulated that molecular determinants Htt biology. Importantly, the Htt-containing module beyond the polyQ repeat itself may be critical to disease patho- is highly enriched with proteins involved in 14-3-3 genesis (Orr and Zoghbi, 2007). signaling, microtubule-based transport, and proteo- Protein-interacting cis-domains (Lim et al., 2008) and post- stasis. Top-ranked proteins in this module were vali- translational modifications (PTMs) of polyQ proteins (Emamian dated as Htt interactors and genetic modifiers in an et al., 2003; Gu et al., 2009) can significantly modify disease path- HD Drosophila model. Our study provides a compen- ogenesis in vivo. Thus, studying the proteins that interact with dium of spatiotemporal Htt-interacting proteins in domains beyond the polyQ region may provide important clues to disease mechanisms. In the case of HD, several hundred puta- the mammalian brain and presents an approach for tive Htt interactors have been discovered using ex vivo methods, analyzing proteomic interactome data sets to build such as yeast two-hybrid (Y2H) or in vitro affinity pull-down in vivo protein networks in complex tissues, such assays, utilizing only small N-terminal fragments of Htt (Goehler as the brain. et al., 2004; Kaltenbach et al., 2007). Such studies have provided insight into Htt’s normal function as a scaffolding protein involved in vesicular and axonal transport and nuclear transcription (Cav- INTRODUCTION iston and Holzbaur, 2009; Li and Li, 2006). The caveats of the prior Htt interactome studies include the exclusive use of small Htt Huntington’s disease (HD) is one of the most common domi- N-terminal fragments as baits and the isolation of interactors nantly inherited neurodegenerative disorders clinically charac- ex vivo. Hence, it is not known which proteins can complex terized by a triad of movement disorder, cognitive dysfunction, with full-length Htt (fl-Htt) in vivo within distinct brain regions and psychiatric impairment (Bates et al., 2002). HD neuropa- and at different ages. Such information may shed light on age- thology is characterized by selective and massive degeneration dependent, selective neuropathogenesis in HD. Neuron 75, 41–57, July 12, 2012 ª2012 Elsevier Inc. 41 Neuron Huntingtin Interactome Network in Mammalian Brain Figure 1. Generation and Characterization of a Full-Length Htt In Vivo Proteomic Interactome from BACHD and Wild-Type Mouse Brains (A) Immunoprecipitation using a human Htt-selective antibody (aa 1,844–2,131, clone HDB4E10) followed by western blot analysis using a human and mouse Htt antibody (MAB2166) confirms full-length Htt is pulled down in both 2-month WT and 2- and 12-month BACHD soluble cortical extracts. A negative control (no Htt antibody) and 5% input loading control were also included. (B) The affinity purification followed by mass spectrometry (AP-MS) proteomic approach used to identify endogenous fl-Htt protein interactors: (1) The cortex, striatum, and cerebellum of 2- and 12-month WT and BACHD mice were homogenized; (2) the soluble lysates were subjected to anti-Htt IP using HDB4E10 and Protein G Dynabeads; (3) the immunoprecipitates were eluted with LDS loading buffer, separated on an SDS-PAGE gel, each gel was cut into 24–27 gel bands, and each gel band was subjected to in-gel trypsin digestion; (4) approximately 750 independent LC-MS/MS analysis were performed, and (5) all mass spectra were searched using MASCOT (Matrix Science) to obtain a total of 747 high-scoring, putative Htt-interacting proteins. 42 Neuron 75, 41–57, July 12, 2012 ª2012 Elsevier Inc. Neuron Huntingtin Interactome Network in Mammalian Brain Immunoaffinity purification of native protein complexes AP-MS strategy of using HDB4E10 should be considered as a followed by identification of its individual components using survey of in vivo Htt-complexed proteins regardless of Htt polyQ mass spectrometry (MS) has emerged as a powerful tool for length. This is a reasonable strategy since full-length human deciphering in vivo neuronal signaling (Husi et al., 2000), and mHtt can fully substitute the essential function of murine Htt in synaptic and disease-related interactomes (Selimi et al., 2009; murine embryonic development (Gray et al., 2008), and hence Ferna´ ndez et al., 2009). Although a ‘‘shotgun’’ proteomic both forms should share the majority of in vivo interacting approach is useful in creating a list of native-interacting protein proteins. candidates from relevant mammalian tissues, formidable chal- Human and/or murine fl-Htt complexes were immunoaffinity lenges exist in the unbiased bioinformatic analyses of such purified from the cortex, striatum, and cerebellum of BACHD complex proteomic data sets to identify high-confidence inter- and WT mice at 2 or 12 months of age using HDB4E10 actors and to build accurate, endogenous protein interaction (Figure 1B). As a negative control, a mock IP for each sample networks (Liao et al., 2009). condition (defined by specific brain region, age, and genotype) In this study, we performed a spatiotemporal in vivo proteomic was performed in the absence of the Htt antibody. Therefore, interactome study of fl-Htt using dissected brain regions from a total of 30 independent IP experiments were performed, and a mouse model for HD and wild-type controls. The BACHD approximately 765 trypsin-digested gel slices were subjected mouse model used in the study expresses full-length human to LC-MS/MS analysis (Figure 1C). Using the MASCOT (Matrix mutant Htt (mHtt) with 97Q under the control of human Htt Science) sequence database-searching tool, we identified a total genomic regulatory elements on a BAC transgene (Gray et al., of 747 high-scoring, putative Htt-interacting proteins from 2008). BACHD mice exhibit multiple disease-like phenotypes BACHD and WT mouse brains (Table S1 available online). over the course of 12 months, including progressive motor, Consistent with the claim that we are surveying fl-Htt-interacting cognitive, and psychiatric-like deficits and selective cortical proteins, we identified Htt peptides spanning the entire and striatal atrophy (Gray et al., 2008; Menalled et al., 2009). sequence of Htt in both BACHD and WT samples (Figure 1D Our multidimensional affinity purification-mass spectrometry and Table S2). As confirmation that HDB4E10 more efficiently (AP-MS) study uncovered a total of 747 candidate proteins com- immunoprecipitates human Htt than murine Htt, we observed plexed with fl-Htt in the mammalian brain. Moreover, we applied more Htt peptides and more extensive sequence coverage of WGCNA to analyze the entire fl-Htt interactome data set to fl-Htt in BACHD mice compared to WT mice. define a verifiable rank of Htt-interacting proteins and to uncover the organization of in vivo fl-Htt-interacting protein networks The In Vivo fl-Htt Interactome Is Enriched with Known in the mammalian brain. Htt Interactors and Proteins Involved in Pathways Relevant to HD RESULTS We next performed several standard bioinformatic analyses to determine the validity of our approach in isolating Htt interactors
Load more

Recommended publications
  • Regulation of SETD2 Stability Is Important for the Fidelity Of
    Bhattacharya and Workman Epigenetics & Chromatin (2020) 13:40 Epigenetics & Chromatin https://doi.org/10.1186/s13072-020-00362-8 RESEARCH Open Access Regulation of SETD2 stability is important for the fdelity of H3K36me3 deposition Saikat Bhattacharya and Jerry L. Workman* Abstract Background: The histone H3K36me3 mark regulates transcription elongation, pre-mRNA splicing, DNA methylation, and DNA damage repair. However, knowledge of the regulation of the enzyme SETD2, which deposits this function- ally important mark, is very limited. Results: Here, we show that the poorly characterized N-terminal region of SETD2 plays a determining role in regulat- ing the stability of SETD2. This stretch of 1–1403 amino acids contributes to the robust degradation of SETD2 by the proteasome. Besides, the SETD2 protein is aggregate prone and forms insoluble bodies in nuclei especially upon proteasome inhibition. Removal of the N-terminal segment results in the stabilization of SETD2 and leads to a marked increase in global H3K36me3 which, uncharacteristically, happens in a Pol II-independent manner. Conclusion: The functionally uncharacterized N-terminal segment of SETD2 regulates its half-life to maintain the requisite cellular amount of the protein. The absence of SETD2 proteolysis results in a Pol II-independent H3K36me3 deposition and protein aggregation. Keywords: Chromatin, Proteasome, Histone, Methylation, Aggregation Background In yeast, the SET domain-containing protein Set2 Te N-terminal tails of histones protrude from the nucle- (ySet2) is the sole H3K36 methyltransferase [10]. ySet2 osome and are hotspots for the occurrence of a variety interacts with the large subunit of the RNA polymerase II, of post-translational modifcations (PTMs) that play key Rpb1, through its SRI (Set2–Rpb1 Interaction) domain, roles in regulating epigenetic processes.
    [Show full text]
  • F8A2 Antibody (N-Term) Affinity Purified Rabbit Polyclonal Antibody (Pab) Catalog # Ap11393a
    苏州工业园区双圩路9号1幢 邮 编 ： 215000 电 话 ： 0512-88856768 F8A2 Antibody (N-term) Affinity Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP11393a Specification F8A2 Antibody (N-term) - Product info Application WB Primary Accession P23610 Other Accession NP_001007525.1, NP_001007524.1, NP_036283.2 Reactivity Human Host Rabbit Clonality Polyclonal Isotype Rabbit IgG Clone Names RB29381 F8A2 Antibody (N-term) - Additional info Gene ID 474383;474384;8263 F8A2 Antibody (N-term) (Cat. Other Names #AP11393a) western blot analysis in CEM Factor VIII intron 22 protein, CpG island protein, F8A1, F8A cell line lysates (35ug/lane).This demonstrates the F8A2 antibody Target/Specificity detected the F8A2 protein (arrow). This F8A2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 12-40 amino acids from the N-terminal region of human F8A2. Dilution WB~~1:1000 Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. Storage Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. Precautions F8A2 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. F8A2 Antibody (N-term) - Protein Information Name F8A1 Function RAB5A effector molecule that is involved in vesicular trafficking of early endosomes (PubMed:<a href="http://www.uniprot.org/citations/16476778" target="_blank">16476778</a>). Mediates the recruitment of HTT by RAB5A onto early endosomes. The HTT- F8A1/F8A2/F8A3-RAB5A complex stimulates early endosomal interaction with actin filaments and inhibits interaction with microtubules, leading to the reduction of endosome motility (PubMed:<a href="http://www.uniprot.org/citations/16476778" target="_blank">16476778</a>).
    [Show full text]
  • The Huntington's Disease Protein Interacts with P53 and CREB
    The Huntington’s disease protein interacts with p53 and CREB-binding protein and represses transcription Joan S. Steffan*, Aleksey Kazantsev†, Olivera Spasic-Boskovic‡, Marilee Greenwald*, Ya-Zhen Zhu*, Heike Gohler§, Erich E. Wanker§, Gillian P. Bates‡, David E. Housman†, and Leslie M. Thompson*¶ *Department of Biological Chemistry, D240 Medical Sciences I, University of California, Irvine, CA 92697-1700; †Department of Biology Center for Cancer Research, Massachusetts Institute of Technology, Building E17-543, Cambridge, MA 02139; ‡Medical and Molecular Genetics, GKT School of Medicine, King’s College, 8th Floor Guy’s Tower, Guy’s Hospital, London SE1 9RT, United Kingdom; and §Max-Planck-Institut fur Molekulare Genetik, Ihnestraße 73, Berlin D-14195, Germany Contributed by David E. Housman, March 14, 2000 Huntington’s Disease (HD) is caused by an expansion of a poly- The amino-terminal portion of htt that remains after cyto- glutamine tract within the huntingtin (htt) protein. Pathogenesis in plasmic cleavage and can localize to the nucleus appears to HD appears to include the cytoplasmic cleavage of htt and release include the polyglutamine repeat and a proline-rich region which of an amino-terminal fragment capable of nuclear localization. We have features in common with a variety of proteins involved in have investigated potential consequences to nuclear function of a transcriptional regulation (22). Therefore, htt is potentially pathogenic amino-terminal region of htt (httex1p) including ag- capable of direct interactions with transcription factors or the gregation, protein–protein interactions, and transcription. httex1p transcriptional apparatus and of mediating alterations in tran- was found to coaggregate with p53 in inclusions generated in cell scription.
    [Show full text]
  • Downloaded from [266]
    Patterns of DNA methylation on the human X chromosome and use in analyzing X-chromosome inactivation by Allison Marie Cotton B.Sc., The University of Guelph, 2005 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in The Faculty of Graduate Studies (Medical Genetics) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) January 2012 © Allison Marie Cotton, 2012 Abstract The process of X-chromosome inactivation achieves dosage compensation between mammalian males and females. In females one X chromosome is transcriptionally silenced through a variety of epigenetic modifications including DNA methylation. Most X-linked genes are subject to X-chromosome inactivation and only expressed from the active X chromosome. On the inactive X chromosome, the CpG island promoters of genes subject to X-chromosome inactivation are methylated in their promoter regions, while genes which escape from X- chromosome inactivation have unmethylated CpG island promoters on both the active and inactive X chromosomes. The first objective of this thesis was to determine if the DNA methylation of CpG island promoters could be used to accurately predict X chromosome inactivation status. The second objective was to use DNA methylation to predict X-chromosome inactivation status in a variety of tissues. A comparison of blood, muscle, kidney and neural tissues revealed tissue-specific X-chromosome inactivation, in which 12% of genes escaped from X-chromosome inactivation in some, but not all, tissues. X-linked DNA methylation analysis of placental tissues predicted four times higher escape from X-chromosome inactivation than in any other tissue. Despite the hypomethylation of repetitive elements on both the X chromosome and the autosomes, no changes were detected in the frequency or intensity of placental Cot-1 holes.
    [Show full text]
  • Transglutaminase-Catalyzed Inactivation Of
    Proc. Natl. Acad. Sci. USA Vol. 94, pp. 12604–12609, November 1997 Medical Sciences Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and a-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length ARTHUR J. L. COOPER*†‡§, K.-F. REX SHEU†‡,JAMES R. BURKE¶i,OSAMU ONODERA¶i, WARREN J. STRITTMATTER¶i,**, ALLEN D. ROSES¶i,**, AND JOHN P. BLASS†‡,†† Departments of *Biochemistry, †Neurology and Neuroscience, and ††Medicine, Cornell University Medical College, New York, NY 10021; ‡Burke Medical Research Institute, Cornell University Medical College, White Plains, NY 10605; and Departments of ¶Medicine, **Neurobiology, and iDeane Laboratory, Duke University Medical Center, Durham, NC 27710 Edited by Louis Sokoloff, National Institutes of Health, Bethesda, MD, and approved August 28, 1997 (received for review April 24, 1997) ABSTRACT Several adult-onset neurodegenerative dis- Q12-containing peptide (16). In the work of Kahlem et al. (16) the eases are caused by genes with expanded CAG triplet repeats largest Qn domain studied was Q18. We found that both a within their coding regions and extended polyglutamine (Qn) nonpathological-length Qn domain (n 5 10) and a longer, patho- domains within the expressed proteins. Generally, in clinically logical-length Qn domain (n 5 62) are excellent substrates of affected individuals n > 40. Glyceraldehyde 3-phosphate dehy- tTGase (17, 18). drogenase binds tightly to four Qn disease proteins, but the Burke et al. (1) showed that huntingtin, huntingtin-derived significance of this interaction is unknown. We now report that fragments, and the dentatorubralpallidoluysian atrophy protein purified glyceraldehyde 3-phosphate dehydrogenase is inacti- bind selectively to glyceraldehyde 3-phosphate dehydrogenase vated by tissue transglutaminase in the presence of glutathione (GAPDH) in human brain homogenates and to immobilized S-transferase constructs containing a Qn domain of pathological rabbit muscle GAPDH.
    [Show full text]
  • ( 12 ) Patent Application Publication ( 10 ) Pub . No .: US 2020/0299658 A1 Hekele Et Al
    US 20200299658A1 INI ( 19 ) United States ( 12 ) Patent Application Publication ( 10 ) Pub . No .: US 2020/0299658 A1 Hekele et al . ( 43 ) Pub . Date : Sep. 24 , 2020 ( 54 ) ENGINEERED NUCLEASES THAT TARGET C12N 5/071 ( 2006.01 ) HUMAN AND CANINE FACTOR VIII GENES C12N 15/113 ( 2006.01 ) AS A TREATMENT FOR HEMOPHILIA A A61K 48/00 ( 2006.01 ) ( 71 ) Applicant: Precision BioSciences , Inc. , Durham , A61K 9/127 ( 2006.01 ) NC (US ) ( 52 ) U.S. CI . CPC ( 72 ) Inventors : Armin Hekele , Cary, NC ( US ) ; C12N 9/22 ( 2013.01 ) ; C12N 15/86 Clayton Beard , Durham , NC ( US ) ; ( 2013.01 ) ; C12N 5/067 ( 2013.01 ) ; C12N Derek Jantz , Durham , NC (US ); James 570672 ( 2013.01 ) ; C12N 15/113 ( 2013.01 ) ; Jefferson Smith , Morrisville , NC ( US ) ; A61K 38/02 ( 2013.01 ) ; A61K 9/127 ( 2013.01 ) ; Victor Bartsevich , Durham , NC (US ) C12N 2750/14143 ( 2013.01 ) ; C12N 2310/20 ( 73 ) Assignee : Precision BioSciences , Inc. , Durham , ( 2017.05 ) ; CI2N 2800/80 ( 2013.01 ) ; A61K NC (US ) 48/005 ( 2013.01 ) ( 21 ) Appl. No .: 16 / 760,902 ( 57 ) ABSTRACT ( 22 ) PCT Filed : Nov. 1 , 2018 The present invention encompasses engineered nucleases which recognize and cleave a recognition sequence within ( 86 ) PCT No .: PCT / US2018 / 058692 the int22h - 1 sequence of a Factor VIII gene . The present $ 371 ( c ) ( 1 ), invention also encompasses methods of using such engi ( 2 ) Date : Apr. 30 , 2020 neered nucleases to make genetically -modified cells , and the use of such cells in a pharmaceutical composition and in Related U.S. Application Data methods for treating hemophilia A. Further, the invention ( 60 ) Provisional application No.
    [Show full text]
  • Literature Mining Sustains and Enhances Knowledge Discovery from Omic Studies
    LITERATURE MINING SUSTAINS AND ENHANCES KNOWLEDGE DISCOVERY FROM OMIC STUDIES by Rick Matthew Jordan B.S. Biology, University of Pittsburgh, 1996 M.S. Molecular Biology/Biotechnology, East Carolina University, 2001 M.S. Biomedical Informatics, University of Pittsburgh, 2005 Submitted to the Graduate Faculty of School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh 2016 UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE This dissertation was presented by Rick Matthew Jordan It was defended on December 2, 2015 and approved by Shyam Visweswaran, M.D., Ph.D., Associate Professor Rebecca Jacobson, M.D., M.S., Professor Songjian Lu, Ph.D., Assistant Professor Dissertation Advisor: Vanathi Gopalakrishnan, Ph.D., Associate Professor ii Copyright © by Rick Matthew Jordan 2016 iii LITERATURE MINING SUSTAINS AND ENHANCES KNOWLEDGE DISCOVERY FROM OMIC STUDIES Rick Matthew Jordan, M.S. University of Pittsburgh, 2016 Genomic, proteomic and other experimentally generated data from studies of biological systems aiming to discover disease biomarkers are currently analyzed without sufficient supporting evidence from the literature due to complexities associated with automated processing. Extracting prior knowledge about markers associated with biological sample types and disease states from the literature is tedious, and little research has been performed to understand how to use this knowledge to inform the generation of classification models from ‘omic’ data. Using pathway analysis methods to better understand the underlying biology of complex diseases such as breast and lung cancers is state-of-the-art. However, the problem of how to combine literature- mining evidence with pathway analysis evidence is an open problem in biomedical informatics research.
    [Show full text]
  • A Dissertation Entitled the Androgen Receptor
    A Dissertation entitled The Androgen Receptor as a Transcriptional Co-activator: Implications in the Growth and Progression of Prostate Cancer By Mesfin Gonit Submitted to the Graduate Faculty as partial fulfillment of the requirements for the PhD Degree in Biomedical science Dr. Manohar Ratnam, Committee Chair Dr. Lirim Shemshedini, Committee Member Dr. Robert Trumbly, Committee Member Dr. Edwin Sanchez, Committee Member Dr. Beata Lecka -Czernik, Committee Member Dr. Patricia R. Komuniecki, Dean College of Graduate Studies The University of Toledo August 2011 Copyright 2011, Mesfin Gonit This document is copyrighted material. Under copyright law, no parts of this document may be reproduced without the expressed permission of the author. An Abstract of The Androgen Receptor as a Transcriptional Co-activator: Implications in the Growth and Progression of Prostate Cancer By Mesfin Gonit As partial fulfillment of the requirements for the PhD Degree in Biomedical science The University of Toledo August 2011 Prostate cancer depends on the androgen receptor (AR) for growth and survival even in the absence of androgen. In the classical models of gene activation by AR, ligand activated AR signals through binding to the androgen response elements (AREs) in the target gene promoter/enhancer. In the present study the role of AREs in the androgen- independent transcriptional signaling was investigated using LP50 cells, derived from parental LNCaP cells through extended passage in vitro. LP50 cells reflected the signature gene overexpression profile of advanced clinical prostate tumors. The growth of LP50 cells was profoundly dependent on nuclear localized AR but was independent of androgen. Nevertheless, in these cells AR was unable to bind to AREs in the absence of androgen.
    [Show full text]
  • The Isolation and Characterization of Huntingtin Interacting
    THE ISOLATION AND CHARACTERIZATION OF HUNTINGTIN INTERACTING PROTEINS By MICHAEL ANDREW KALCHMAN B.Sc. (Honor's Genetics), University of Western Ontario, 1992 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY In THE FACULTY OF GRADUATE STUDIES GENETICS GRADUATE PROGRAMME We accept this thesis as conforming to the required standard THE UNIVERSITY OF BRITISH COLUMBIA JULY, 1998 © Michael Andrew Kalchman 1998 In presenting this thesis in partial fulfilment of the requirements for an advanced degree at the University of British Columbia, I agree that the Library shall make it freely available for reference and study. I further agree that permission for extensive copying of this thesis for scholarly purposes may be granted by the head of my department or by his or her representatives. It is understood that copying or publication of this thesis for financial gain shall not be allowed without my written permission. Department of The University of British Columbia Vancouver, Canada DE-6 (2/88) ABSTRACT Huntington Disease (HD) is an autosomal dominant, neurodegenerative disorder with onset normally occurring at around 40 years of age. This devastating disease is the result of the expression of a polyglutamine tract greater than 35 in a protein with unknown function. The underlying mutation in HD places it in a category of neurodegenerative diseases along with seven other diseases, all of which have widespread expression of the protein with an abnormally long polyglutamine tract, but have disease specific neurodegeneration. Yeast two-hybrid screens were used in an attempt to further elucidate the function of the HD gene product, huntingtin.
    [Show full text]
  • Phosphorylation of Huntingtin at Residue T3 Is Decreased In
    Phosphorylation of huntingtin at residue T3 is PNAS PLUS decreased in Huntington’s disease and modulates mutant huntingtin protein conformation Cristina Cariuloa,1, Lucia Azzollinia,1, Margherita Verania, Paola Martufia, Roberto Boggiob, Anass Chikic, Sean M. Deguirec, Marta Cherubinid,e, Silvia Ginesd,e, J. Lawrence Marshf, Paola Confortig,h, Elena Cattaneog,h, Iolanda Santimonei, Ferdinando Squitierii, Hilal A. Lashuelc,2, Lara Petriccaa,2,3, and Andrea Caricasolea,2,3 aDepartment of Neuroscience, IRBM Science Park, 00071 Pomezia, Rome, Italy; bIRBM Promidis, 00071 Pomezia, Rome, Italy; cLaboratory of Molecular and Chemical Biology of Neurodegeneration, Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland; dDepartamento de Biomedicina, Facultad de Medicina, Instituto de Neurociencias, Universidad de Barcelona, 08035 Barcelona, Spain; eInstitut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain; fDepartment of Developmental and Cell Biology, University of California, Irvine, CA 92697; gLaboratory of Stem Cell Biology and Pharmacology of Neurodegenerative Diseases, Department of Biosciences, University of Milan, 20122 Milan, Italy; hIstituto Nazionale Genetica Molecolare (INGM) Romeo ed Enrica Invernizzi, Milan 20122, Italy; and iHuntington and Rare Diseases Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy Edited by Solomon H. Snyder, Johns Hopkins University School of Medicine, Baltimore, MD, and approved October 25, 2017 (received for review April 10, 2017) Posttranslational modifications can have profound effects on the reviewed in ref. 13). The mutation leads to the production of biological and biophysical properties of proteins associated with huntingtin protein (HTT) bearing a polyglutamine expansion misfolding and aggregation.
    [Show full text]
  • Allele-Specific Regulation of Mutant Huntingtin by Wig1, a Downstream
    Human Molecular Genetics, 2016, Vol. 25, No. 12 2514–2524 doi: 10.1093/hmg/ddw115 Advance Access Publication Date: 19 May 2016 Original Article Downloaded from https://academic.oup.com/hmg/article-abstract/25/12/2514/2525740 by Univ of Connecticut user on 21 May 2019 ORIGINAL ARTICLE Allele-specific regulation of mutant Huntingtin by Wig1, a downstream target of p53 Sun-Hong Kim1,†, Neelam Shahani1,†,‡, Byoung-II Bae2,¶, Juan I. Sbodio2, Youjin Chung1, Kazuhiro Nakaso3, Bindu D. Paul2 and Akira Sawa1,2,* 1Department of Psychiatry and Behavioral Sciences, 2Neuroscience Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA and 3Division of Medical Biochemistry, Department of Pathophysiological and Therapeutic Science, Tottori University Faculty of Medicine, 86, Nishicho, Yonago, 683-8503, Japan *To whom correspondence should be addressed at: Tel: þ1 4109554726; Fax: þ1 4106141792; Email: [email protected] Abstract p53 has been implicated in the pathophysiology of Huntington’s disease (HD). Nonetheless, the molecular mechanism of how p53 may play a unique role in the pathology remains elusive. To address this question at the molecular and cellular biology levels, we initially screened differentially expressed molecules specifically dependent on p53 in a HD animal model. Among the candidate molecules, wild-type p53-induced gene 1 (Wig1) is markedly upregulated in the cerebral cortex of HD patients. Wig1 preferentially upregulates the level of mutant Huntingtin (Htt) compared with wild-type Htt. This allele-specific charac- teristic of Wig1 is likely to be explained by higher affinity binding to mutant Htt transcripts than normal counterpart for the stabilization. Knockdown of Wig1 level significantly ameliorates mutant Htt-elicited cytotoxicity and aggregate formation.
    [Show full text]
  • WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T (51) International Patent Classification: David [US/US]; 13539 N . 95th Way, Scottsdale, AZ C12Q 1/68 (2006.01) 85260 (US). (21) International Application Number: (74) Agent: AKHAVAN, Ramin; Caris Science, Inc., 6655 N . PCT/US20 12/0425 19 Macarthur Blvd., Irving, TX 75039 (US). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 14 June 2012 (14.06.2012) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, English (25) Filing Language: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, Publication Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, (30) Priority Data: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 61/497,895 16 June 201 1 (16.06.201 1) US MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 61/499,138 20 June 201 1 (20.06.201 1) US OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, 61/501,680 27 June 201 1 (27.06.201 1) u s SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, 61/506,019 8 July 201 1(08.07.201 1) u s TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]